Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
11.19 | 41.44 | -72.99% | 0 | 0% |
| P/S |
|
1.08 | 20.2 | -94.65% |
|
|
| P/BV |
|
1.07 | 3.68 | -70.9% |
|
|
| P/FCF |
|
0 | 82.02 | -100% |
|
|
| Ev/Ebitda |
|
15.48 | 16.62 | -6.88% |
|
|
| Ev/S |
|
2.13 | 25.64 | -91.68% |
|
|
| Ev/FCF |
|
0 | 85.08 | -100% |
|
|
| E/P |
|
0.054 | 0.0217 | 149.09% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
4/10
|
13.28 | -99.16 | -113.39% | 13.28 | 0% |
| ROE |
|
8.61 | 6.65 | 29.43% |
|
|
| ROA |
|
2.25 | 3.59 | -37.26% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
9.59 | -76.75 | -112.5% |
|
|
| ROCE |
|
0 | 19.43 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
0/10
|
5.22 | 0.7406 | 604.46% | 5.22 | 0% |
| Nеt Debt/Ebitda |
|
0 | -0.1122 | -100% |
|
|
| Debt/Ratio |
|
0 | 0.1008 | -100% |
|
|
| Debt/Equity |
|
0 | 0.212 | -100% |
|
|
| Debt/Net Income |
|
7.23 | 1.37 | 425.75% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
5.85/10
|
2.34 | 0.3991 | 486.31% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1 | -100% | ||
| DSI |
|
1 | 0.6935 | 44.2% |
|
|
| Average dividend growth |
|
0 | 3.04 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.4 | -100% |
|
|
| Average percentage for payments |
|
0 | 45.07 | -100% |
|
|
| Difference from average difference in sector |
|
1.94 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
3/10
|
0 | 23.95 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
0 | 12.85 | -100% | ||
| Growth impulse Net Income in 5 years |
|
0 | 62.77 | -100% | ||
| Growth impulse FCF in 5 years |
|
0 | 30.4 | -100% | ||
| Growth impulse EPS in 5 years |
|
0 | 82.9 | -100% |
IP Score
4.72/10
